Kenneth W. Narducy

Kenneth W. Narducy

President at
St. Charles Pharmaceuticals
Health Technology
Consumer Services

Profile

Kenneth W.
Narducy
is currently the Chief Operating Officer & Director at NeuroNascent, Inc. and the President at St. Charles Pharmaceuticals.
Previously, he held positions such as Chairman at Colby Pharmaceutical Co. from 2006 to 2013, Manager-Research & Development at Abbott Laboratories, Vice President-Research & Development at Wesley Jessen VisionCare, Inc., Vice President & General Manager at Centaur Pharmaceuticals, Inc., President & Executive Vice President at Oculex Pharmaceuticals, Inc., and Vice President-Research & Development at CooperVision Pharmaceuticals, Inc. Dr. Narducy holds an MBA degree from The University of Chicago and a doctorate degree from The Ohio State University.

Kenneth W. Narducy active positions

CompaniesPositionStart
St. Charles Pharmaceuticals
President 17/09/2009
Chief Operating Officer -

Former positions of Kenneth W. Narducy

CompaniesPositionEnd
Chairman 01/01/2013
ABBOTT LABORATORIES Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
CooperVision Pharmaceuticals, Inc.
Chief Tech/Sci/R&D Officer -
President -
See the detail of Kenneth W. Narducy's experience

Training of Kenneth W. Narducy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

6

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

St. Charles Pharmaceuticals

CooperVision Pharmaceuticals, Inc.

Health Technology

  1. Stock Market
  2. Insiders
  3. Kenneth W. Narducy
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!